文献速递糖尿病

二甲双胍:在2型糖尿病中的临床应用

Metformin: clinical use in type 2 diabetes.
PubMed 文献 · Diabetologia · 2017-08-02

二甲双胍是广泛使用的口服降糖药,被EASD和ADA等指南推荐为2型糖尿病的一线治疗,其优势在于疗效、低成本、体重中立和良好的安全性。近年对轻中度慢性肾病患者的使用限制趋于宽松,但缺乏与新型降糖药的长期对比研究,其「基础治疗」地位可能受到挑战。

要点

  • 二甲双胍被EASD和ADA等指南推荐为2型糖尿病的一线治疗。
  • 其优势包括疗效、低成本、体重中立和良好的安全性。
  • 缺乏与新型降糖药的长期对比研究,其基础治疗地位可能受到挑战。

核心结论

  • 二甲双胍被广泛认为是2型糖尿病的最佳初始治疗,并被EASD和ADA等指南推荐为一线治疗。
  • 缺乏与新型降糖药的长期对比研究,其「基础治疗」地位可能受到合理挑战。

研究设计与样本

  • 原文为综述,未报告系统检索范围。

主要发现

  • 二甲双胍的确切作用机制仍存在争议,被认为涉及减少肝葡萄糖生成。
  • 除降糖外,还报告了某些血脂和炎症标志物的改善以及心血管事件的减少,似乎独立于降糖效应。
  • 数据对既往在轻中度慢性肾病患者中不愿使用该药提出质疑,近年对稳定、轻度肾功能不全患者的使用规定已变得更宽松。

关键数值与推荐

  • 原文未报告具体数值标准。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出仍存在关于该药确切作用机制的争议。
  • 原文指出缺乏与新型降糖药的长期对比研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Metformin is one of the most popular oral glucose-lowering medications, widely considered to be the optimal initial therapy for patients with type 2 diabetes mellitus. Interestingly, there still remains controversy regarding the drug's precise mechanism of action, which is thought to involve a reduction in hepatic glucose production. It is now recommended as first-line treatment in various guidelines, including that of the EASD and ADA. Its favoured status lies in its efficacy, low cost, weight neutrality and good safety profile. Other benefits have also been described, including improvements in certain lipids, inflammatory markers, and a reduction in cardiovascular events, apparently independent from the drug's glucose-lowering effect. Data have emerged questioning the previous reluctance to use this agent in those with mild to moderate chronic kidney disease. Regulations guiding its use in patients with stable, modest renal dysfunction have, as a result, become more lenient in recent years. With no long-term studies comparing it against newer glucose-lowering drugs, some of which have more robust evidence for cardioprotection, metformin's established role as 'foundation therapy' in type 2 diabetes may justifiably be challenged.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Sanchez-Rangel E, Inzucchi SE. Metformin: clinical use in type 2 diabetes. Diabetologia. 2017. PMID: 28770321. doi:10.1007/s00125-017-4336-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。